LMO1 and colorectal carcinoma: Despite not being a transcription factor itself, lmo1 was identified as the key regulatory switch that, as a consequence of GATA3 binding, creates a super enhancer that governs which CRC is activated: the more lineage-committed pro-NBL adrenergic CRC program or the less differentiated mesenchymal CRC program.